Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury

Experimental Neurology

Volumn 190, Issue 1, 2004, Pages 192-203

  Ikonomovic, Milos D ^a   Uryu, Kunihiro ^b   Abrahamson, Eric E ^a   Ciallella, John R ^a   Trojanowski, John Q ^b   Lee, Virginia M Y ^b   Clark, Robert S ^a   Marion, Donald W ^a   Wisniewski, Stephen R ^a   DeKosky, Steven T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

A plaque; Alzheimer's disease; Glial cell

Indexed keywords

ALPHA SYNUCLEIN; APOLIPOPROTEIN E; BETA SYNUCLEIN; BIOCHEMICAL MARKER; GAMMA SYNUCLEIN; PROTEIN PRECURSOR; TAU PROTEIN; UBIQUITIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN INJURY; BRAIN SURGERY; CARBOXY TERMINAL SEQUENCE; CELL STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIA CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR DYNAMICS; NERVE CELL; NERVE CELL DEGENERATION; NERVE DEGENERATION; NERVE FIBER; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SPECIES; STATISTICAL SIGNIFICANCE; SYMPTOM; TEMPORAL CORTEX;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; BRAIN INJURIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROPIL; PEPTIDE FRAGMENTS; RISK; SENILE PLAQUES; TEMPORAL LOBE;

EID: 5044237263     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.06.011     Document Type: Article

References (71)

1. Altstiel L.D., Sperber K. Cytokines in Alzheimer's disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 15:1991;481-495
2. Anonymous National Institute on Aging and Reagan Institute working group on diagnosis criteria for the neuropathological assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of AD. Neurobiol. Aging. 18:1997;S1-S3
3. Arai T., Ikeda K., Akiyama H., Haga C., Usami M., Sahara N., Iritani S., Mori H. A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein deposits. Acta Neuropathol. 97:1999;82-84
4. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging. 18:1997;351-357
5. Butterfield D.A., Griffin S., Munch G., Pasinetti G.M. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J. Alzheimer's Dis. 4:2002;193-201
6. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S., Greengard P. Cholinergic agonists and interleukin-1 regulate processing and secretion of the Alzheimer ß/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10075-10078
7. Ciallella J.R., Ikonomovic M.D., Paljug W.R., Wilbur Y.I., Dixon C.E., Kochanek P.M., Marion D.W., DeKosky S.T. Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J. Neurotrauma. 12:2002;1555-1567
8. Clark R.S.B., Kochanek P.M., Chen M., Watkins S.C., Marion D.W., Chen J., Hamilton R.L., Loeffert J.E., Graham S.H. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB. 13:1999;813-821
9. Clifton G.L., Allen S., Barrodale P., Plenger P., Berry J., Koch S., Fletcher J., Hayes R.L., Choi S.C. A phase II study of moderate hypothermia in severe brain injury. J. Neurotrauma. 10:1993;263-271
10. Clinton J., Ambler M.W., Roberts G.W. Post-traumatic Alzheimer's disease: preponderance of a single plaque type. Neuropathol. Appl. Neurobiol. 17:1991;69-74
11. Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., Masdeu J., Kawas C., Aronson M., Wolfson L. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 38:1988;1682-1687
12. Dayan A.D. Quantitative histological studies on the aged human brain. I. Senile plaques and neurofibrillary tangles in "normal" patients. Acta Neuropathol. 16:1970;85-94
13. DeKosky S.T., Kochanek P.M., Clark R.S.B., Ciallella J.R., Dixon C.E. Secondary injury after head trauma: subacute and long-term mechanisms. Semin. Clin. Neuropsychiatry. 3:1998;176-185
14. Delaere P., Duyckaerts C., Masters C., Beyreuther K., Piette F., Hauw J.J. Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci. Lett. 116:1990;87-93
15. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., Blau A.D., Davies P., Yen S.H., Aronson M.K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 13:1991;179-189
16. Forloni G., Demicheli F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal, and glial cells: modulation by interleukin-1. Brain Res., Mol. Brain Res. 16:1992;128-134
17. Geddes J.F., Vowles G.H., Nicoll J.A., Revesz T. Neuronal cytoskeletal changes are an early consequence of repetitive head injury. Acta Neuropathol. 98:1999;171-178
18. Gentleman S.M., Graham D.I., Roberts G.W. Molecular pathology of head trauma: altered β APP metabolism and the aetiology of Alzheimer's disease. Kogure K., Hossmann K.-A., Siesjo B.K. Progress in Brain Research. vol. 96:1993;237-246 Elsevier Science Publishers B.V., New York
19. Gentleman S.M., Greenberg B.D., Savage M.J., Noori M., Newman S.J., Roberts G.W., Griffin W.S., Graham D.I. A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. NeuroReport. 8:1997;1519-1522
20. Gomez-Isla T., West H.L., Rebeck G.W., Harr S.D., Growdon J.H., Locascio J.J., Perls T.T., Lipsitz L.A., Hyman B.T. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann. Neurol. 39:1996;62-70
21. Graham D.I., Gentleman S.M., Lynch A., Roberts G.W. Distribution of B-amyloid protein in the brain following severe head injury. Neuropathol. Appl. Neurobiol. 21:1995;27-34
22. Griffin W.S.T., Stanley L.C., Ling C., White L., Macleod V., Perrot L.J., White C.L. III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7611-7615
23. Griffin W.S., Sheng J.G., Roberts G.W., Mrak R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54:1995;276-281
24. Guo Z., Cupples L.A., Kurz A., Auerbach S.H., Volicer L., Chui H., Green R.C., Sadovnick A.D., Duara R., DeCarli C., Johnson K., Go R.C., Growdon J.H., Haines J.L., Kukull W.A., Farrer L.A. Head injury and the risk of AD in the MIRAGE study. Neurology. 54:2000;1316-1323
25. Hardy J. An "anatomical cascade hypothesis" for Alzheimer's disease. Trends Neurosci. 15:1992;200-201
26. Hartman R.E., Laurer H., Longhi L., Bales K.R., Paul S.M., McIntosh T.K., Holtzman D.M. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. J. Neurosci. 22:2002;10083-10087
27. Horsburgh K., Cole G.M., Yang F., Savage M.J., Greenberg B.D., Gentleman S.M., Graham D.I., Nicoll J.A. β-amyloid (Aβ)42(43), aβ42, aβ40 and apoE immunostaining of plaques in fatal head injury. Neuropathol. Appl. Neurobiol. 26:2000;124-132
28. Ikonomovic M.D., Mizukami K., Davies P., Sheffield R., Armstrong D.M. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains. J. Neuropathol. Exp. Neurol. 56:1997;1018-1027
29. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aß monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron. 13:1994;45-53
30. Iwatsubo T., Mann D., Odaka A., Suzuki N., Ihara Y. Amyloid protein (A) deposition: A 42(43) precedes A 40 in Down syndrome. Ann. Neurol. 37:1995;294-299
31. Jennett B., Snoek J., Bond M.R., Brooks N. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J. Neurol., Neurosurg. Psychiatry. 44:1981;285-293
32. Katzman R., Terry R., DeTeresa R., Brown T., Davies P., Fuld P., Renbing X., Peck A. Clinical, pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23:1988;138-144
33. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105
34. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24:2001;1121-1159
35. Luukinen H., Viramo P., Koski K., Laippala P., Kivela S.L. Head injuries and cognitive decline among older adults: a population-based study. Neurology. 55:1999;557-562
36. Mackenzie I.R. Senile plaques do not progressively accumulate with normal aging. Acta Neuropathol. 87:1994;520-525
37. Marion D.W., Penrod L.E., Kelsey S.F., Obrist W.D., Kochanek P.M., Palmer A.M., Wisniewski S.R., DeKosky S.T. Treatment of traumatic brain injury with moderate hypothermia. N. Engl. J. Med. 336:1997;540-546
38. Marshall L.F., Gautille T., Klauber M.R. The outcome of severe closed head injury. J. Neurosurg. 75:1991;S28-S36
39. Masumura M., Hata R., Uramoto H., Murayama N., Ohno T., Sawada T. Altered expression of amyloid precursors proteins after traumatic brain injury in rats: in situ hybridization and immunohistochemical study. J. Neurotrauma. 17:2000;123-134
40. Matsuo E.S., Shin R.-W., Billingsley M.L., Van de Voorde A., O'Connor M., Trojanowski J.Q., Lee V.M.-Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 13:1994;989-1002
41. Mayeux R., Stern Y., Ottman R., Tatemichi T.K., Tang M.-X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein E4 allele in patients with Alzheimer's diseases. Ann. Neurol. 34:1993;752-754
42. Mayeux R., Ottman R., Tang M.X., Noboabauza L., Marder K., Gurland B., Stern Y. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their 1st-degree relatives. Ann. Neurol. 33:1993;494-501
43. Mayeux R., Ottman R., Maestre G., Ngai C., Tang M.-T., Ginsberg H., Chun M., Tycko B., Shelanski M. Synergistic effects of traumatic head injury and apolipoprotein-E4 in patients with Alzheimer's disease. Neurology. 45:1995;555-557
44. McIntosh T.K., Saatman K.E., Raghupathi R., Graham D.I., Smith D.H., Lee V.M., Trojanowski J.Q. The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropathol. Appl. Neurobiol. 24:1998;251-267
45. McKenzie J.E., Gentleman S.M., Roberts G.W., Graham D.I., Royston M.C. Increased numbers of βAPP-immunoreactive neurones in the entorhinal cortex after head injury. NeuroReport. 6:1994;161-164
46. McNamara M.J., Gomez-Isla T., Hyman B.T. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease. Arch. Neurol. 55:1998;1001-1004
47. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486
48. Murakami N., Yamaki T., Iwamoto Y., Sakakibara T., Kobori N., Fushiki S., Ueda S. Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J. Neurotrauma. 15:1998;993-1003
49. Nakagawa Y., Nakamura M., McIntosh T.K., Rodriguez A., Berlin J.A., Smith D.H., Saatman K.E., Raghupathi R., Clemens J., Saido T.C., Schmidt M.L., Lee V.M.-Y., Trojanowski J.Q. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging. J. Comp. Neurol. 411:1999;390-398
50. Nakagawa Y., Reed L., Nakamura M., McIntosh T.K., Smith D.H., Saatman K.E., Raghupathi R., Clemens J., Saido T.C., Lee V.M.-Y., Trojanowski J.Q. Brain trauma in aged transgenic mice induces regression of established Abeta deposits. Exp. Neurol. 163:2000;244-252
51. Nemetz P.N., Leibson C., Naessens J.M., Beard M., Kokmen E., Annegers J.F., Kurland L.T. Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study. Am. J. Epidemiol. 149:1999;32-40
52. Newell K.L., Boyer P., Gomez-Tortosa E., Hobbs W., Hedley-White E.T., Vonsattel J.P., Hyman B.T. Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury. J. Neuropathol. Exp. Neurol. 58:1999;1263-1268
53. Nicoll J.A., Roberts G.W., Graham D.I. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat. Med. 1:1995;135-137
54. Pierce J.E.S., Trojanowski J.Q.T., Graham D.I., Smith D.H., McIntosh T.K. Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and B-amyloid peptide after experimental brain injury in the rat. J. Neurosci. 16:1996;1083-1090
55. Plassman B.L., Havlik R.J., Steffens D.C., Helms M.J., Newman T.N., Drosdick D., Phillips C., Gau B.A., Welsh-Bohmer K.A., Burke J.R., Guralnik J.M., Breitner J.C. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology. 55:2000;1158-1160
56. Roberts G.W. Immunocytochemistry of neurofibrillary tangles in dementia pugilistica and Alzheimer's disease: evidence for common genesis. Lancet. 2:1988;1456-1458
57. Roberts G.W., Gentleman S.M., Lynch A., Graham D.I. βA4 amyloid protein deposition in brain after head trauma. Lancet. 338:1991;1422-1423
58. Roberts G.W., Nash M., Ince P.G., Royston M.C., Gentleman S.M. On the origin of Alzheimer's disease: a hypothesis. Clin. Neurosci. Neuropathol. 4:1993;7-9
59. Roberts G.W., Gentleman S.M., Lynch A., Murray L., Landon M., Graham D.I. β amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol., Neurosurg. Psychiatry. 57:1994;419-425
60. Rothwell N., Allan S., Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100:1997;2648-2652
61. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late onset Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90:1993;9649-9653
62. Schmidt M.L., Zhukareva V., Newell K.L., Lee V.M.-Y., Trojanowski J.Q. Tau isofom profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol. 101:2001;518-524
63. Schofield P.W., Tang M., Marder K., Bell K., Dooneief G., Chun M., Sano M., Stern Y., Mayeux R. Alzheimer's disease after remote head injury: an incidence study. J. Neurol., Neurosurg. Psychiatry. 62:1997;119-124
64. Smith D.H., Nakamura M., McIntosh T.K., Wang J., Rodriguez A., Chen X.-H., Raghupathi R., Saatman K.E., Clemens J., Schmidt M.L., Lee V.M.-Y., Trojanowski J.Q. Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein. Am. J. Pathol. 153:1998;1005-1010
65. Smith D.H., Chen X.H., Nonaka M., Trojanowski J.Q., Lee V.M., Saatman K.E., Leoni M.J., Xu B.N., Wolf J.A., Meaney D.F. Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J. Neuropathol. Exp. Neurol. 58:1999;982-992
66. Stone J.R., Singleton R.H., Povlishock J.T. Antibodies to the C-terminus of the beta-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury. Brain Res. 871:2000;288-302
67. Styren S.D., Hamilton R.L., Styren G.C., Klunk W.E. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J. Histochem. Cytochem. 48:2000;1223-1232
68. Teasdale G., Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 2:1974;81-84
69. Trojanowski J.Q., Lee V.M.-Y. Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses. Neurotoxicology. 23:2002;457-460
70. Uryu K., Laurer H., McIntosh T., Pratico D., Martinez D., Leight S., Lee V.M., Trojanowski J.Q. Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J. Neurosci. 22:2002;446-454
71. Wilson C.A., Doms R.W., Lee V.M. Intracellular APP processing and A beta production in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58:1999;787-794